Vertex Pharmaceuticals Incorporated (VRTX)

NASDAQ: VRTX · Real-Time Price · USD

Compare

484.15

+15.77 (3.37%)

At close: Jan 7, 2026, 4:00 PM EST

482.90

-1.25 (-0.26%)

After-hours: Jan 7, 2026, 4:28 PM EST

Vertex Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Operating Revenue	11,693	11,020	9,869	8,931	7,573	6,203	Upgrade
Other Revenue	30.7	-	-	-	1	2.9	Upgrade
Revenue	11,723	11,020	9,869	8,931	7,574	6,206	Upgrade
Revenue Growth (YoY)	10.33%	11.66%	10.51%	17.91%	22.06%	49.08%	Upgrade
Cost of Revenue	5,543	5,161	4,425	3,608	2,842	2,381	Upgrade
Gross Profit	6,180	5,859	5,444	5,323	4,732	3,825	Upgrade
Selling, General & Admin	1,644	1,464	1,137	944.7	840.1	770.5	Upgrade
Operating Expenses	1,644	1,464	1,137	944.7	840.1	770.5	Upgrade
Operating Income	4,536	4,395	4,308	4,378	3,892	3,054	Upgrade
Interest Expense	-12.8	-30.6	-44.1	-54.8	-61.5	-58.2	Upgrade
Interest & Investment Income	497.2	598.1	614.7	144.6	4.9	22.2	Upgrade
Currency Exchange Gain (Loss)	-38.8	-27.3	-24.6	-15.1	-13.9	-16.1	Upgrade
Other Non Operating Income (Expenses)	25.2	-49.3	9.3	-0.6	1.7	0.8	Upgrade
EBT Excluding Unusual Items	5,007	4,886	4,863	4,453	3,824	3,003	Upgrade
Gain (Loss) on Sale of Investments	-15.5	-9.5	-7.5	-149.1	17.1	311.9	Upgrade
Asset Writedown	-379	-	-	-13	-	-	Upgrade
Other Unusual Items	-	0.5	51.6	57.5	3.1	-13.1	Upgrade
Pretax Income	4,449	248.5	4,380	4,232	2,730	3,117	Upgrade
Income Tax Expense	773.6	784.1	760.2	910.4	388.3	405.2	Upgrade
Earnings From Continuing Operations	3,675	-535.6	3,620	3,322	2,342	2,712	Upgrade
Net Income to Company	3,675	-535.6	3,620	3,322	2,342	2,712	Upgrade
Net Income	3,675	-535.6	3,620	3,322	2,342	2,712	Upgrade
Net Income to Common	3,675	-535.6	3,620	3,322	2,342	2,712	Upgrade
Net Income Growth	-	-	8.96%	41.84%	-13.63%	130.43%	Upgrade
Shares Outstanding (Basic)	257	258	258	256	258	260	Upgrade
Shares Outstanding (Diluted)	258	258	261	259	260	263	Upgrade
Shares Change (YoY)	0.11%	-1.00%	0.54%	-0.31%	-1.33%	1.04%	Upgrade
EPS (Basic)	14.32	-2.08	14.05	12.97	9.09	10.44	Upgrade
EPS (Diluted)	14.22	-2.08	13.89	12.82	9.01	10.29	Upgrade
EPS Growth	-	-	8.35%	42.29%	-12.44%	128.16%	Upgrade
Free Cash Flow	3,337	-790.3	3,337	3,925	2,409	2,994	Upgrade
Free Cash Flow Per Share	12.92	-3.06	12.81	15.15	9.27	11.37	Upgrade
Gross Margin	52.72%	53.17%	55.16%	59.60%	62.48%	61.63%	Upgrade
Operating Margin	38.70%	39.88%	43.65%	49.03%	51.39%	49.21%	Upgrade
Profit Margin	31.35%	-4.86%	36.68%	37.20%	30.92%	43.70%	Upgrade
Free Cash Flow Margin	28.47%	-7.17%	33.81%	43.95%	31.80%	48.24%	Upgrade
EBITDA	4,712	4,577	4,477	4,527	4,018	3,164	Upgrade
EBITDA Margin	40.19%	41.53%	45.36%	50.69%	53.05%	50.98%	Upgrade
D&A For EBITDA	175.4	182	169.5	148.3	125.6	109.5	Upgrade
EBIT	4,536	4,395	4,308	4,378	3,892	3,054	Upgrade
EBIT Margin	38.70%	39.88%	43.65%	49.03%	51.39%	49.21%	Upgrade
Effective Tax Rate	17.39%	315.53%	17.36%	21.51%	14.22%	13.00%	Upgrade
Revenue as Reported	703.2	-	-	-	7,574	6,206	Upgrade

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q